These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27558613)

  • 21. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway.
    Han JH; Ryu HH; Jun MH; Jang DJ; Lee JA
    Biochem Biophys Res Commun; 2012 May; 421(3):544-9. PubMed ID: 22521643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontotemporal dementia caused by CHMP2B mutations.
    Isaacs AM; Johannsen P; Holm I; Nielsen JE;
    Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.
    Yamazaki Y; Takahashi T; Hiji M; Kurashige T; Izumi Y; Yamawaki T; Matsumoto M
    Neurosci Lett; 2010 Jun; 477(2):86-90. PubMed ID: 20420883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ik2/TBK1 and Hook/Dynein, an adaptor complex for early endosome transport, are genetic modifiers of FTD-associated mutant CHMP2B toxicity in Drosophila.
    Lu Y; West RJH; Pons M; Sweeney ST; Gao FB
    Sci Rep; 2020 Aug; 10(1):14221. PubMed ID: 32848189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration.
    Cannon A; Baker M; Boeve B; Josephs K; Knopman D; Petersen R; Parisi J; Dickison D; Adamson J; Snowden J; Neary D; Mann D; Hutton M; Pickering-Brown SM
    Neurosci Lett; 2006 May; 398(1-2):83-4. PubMed ID: 16431024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
    Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
    Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.
    Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y
    J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3.
    Chandrasekaran A; Dittlau KS; Corsi GI; Haukedal H; Doncheva NT; Ramakrishna S; Ambardar S; Salcedo C; Schmidt SI; Zhang Y; Cirera S; Pihl M; Schmid B; Nielsen TT; Nielsen JE; Kolko M; Kobolák J; Dinnyés A; Hyttel P; Palakodeti D; Gorodkin J; Muddashetty RS; Meyer M; Aldana BI; Freude KK
    Stem Cell Reports; 2021 Nov; 16(11):2736-2751. PubMed ID: 34678206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESCRT, autophagy, and frontotemporal dementia.
    Lee JA; Gao FB
    BMB Rep; 2008 Dec; 41(12):827-32. PubMed ID: 19123971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference.
    Nielsen TT; Mizielinska S; Hasholt L; Isaacs AM; Nielsen JE;
    J Gene Med; 2012 Aug; 14(8):521-9. PubMed ID: 22786763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia.
    Canals I; Comella-Bolla A; Cepeda-Prado E; Avaliani N; Crowe JA; Oburoglu L; Bruzelius A; King N; Pajares MA; Pérez-Sala D; Heuer A; Rylander Ottosson D; Soriano J; Ahlenius H
    Brain Commun; 2023; 5(3):fcad158. PubMed ID: 37274831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia.
    Schumacher A; Friedrich P; Diehl-Schmid J; Ibach B; Eisele T; Laws SM; Förstl H; Kurz A; Riemenschneider M
    Neurobiol Aging; 2007 Nov; 28(11):1789-90. PubMed ID: 16979267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The identification of high-performing antibodies for Charged multivesicular body protein 2b for use in Western Blot, immunoprecipitation and immunofluorescence.
    Alshafie W; Fotouhi M; Ayoubi R; Shlaifer I; Southern K; McPherson PS; Laflamme C;
    F1000Res; 2023; 12():884. PubMed ID: 37635943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical Frontoparietal Network Dysfunction in
    Musaeus CS; Pedersen JS; Kjær TW; Johannsen P; Waldemar G; Haverberg MJN; Bacher T; Nielsen JE; Roos P;
    Front Aging Neurosci; 2021; 13():714220. PubMed ID: 34588974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variability in CHMP2B and frontotemporal dementia.
    Momeni P; Rogaeva E; Van Deerlin V; Yuan W; Grafman J; Tierney M; Huey E; Bell J; Morris CM; Kalaria RN; van Rensburg SJ; Niehaus D; Potocnik F; Kawarai T; Salehi-Rad S; Sato C; St George-Hyslop P; Hardy J
    Neurodegener Dis; 2006; 3(3):129-33. PubMed ID: 16954699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of an induced pluripotent stem cell line (ICNDXHi001-A) from a patient with frontotemporal dementia carrying a heterozygous mutation c.796C > G (p.L266V) in MAPT.
    Cai H; Pang Y; Jia L
    Stem Cell Res; 2022 Mar; 59():102654. PubMed ID: 34995843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
    Kurashige T; Takahashi T; Yamazaki Y; Hiji M; Izumi Y; Yamawaki T; Matsumoto M
    Neuropathology; 2013 Jun; 33(3):237-45. PubMed ID: 22989140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients.
    Kaivorinne AL; Krüger J; Udd B; Majamaa K; Remes AM
    Eur J Neurol; 2010 Nov; 17(11):1393-5. PubMed ID: 20412296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.